 The FDA has approved a second drug, denatumab, to treat Alzheimer's. CBS's Dr. John LaPook. This is the second drug available for Alzheimer's patients with early symptoms, early symptoms. It works by using an antibody to remove amyloid plaques that damage the brain. CBS News Brief. I'm Deborah Rodriguez.